[The unsolved problem of diabetes mellitus type 2 and associated complications]

M Morcos1, P Humpert, A Bierhaus

  • 1Medizinische Klinik (Krehl-Klinik), Abteilung Innere Medizin 1 und Klinische Chemie, Universitätsklinikum Heidelberg, INF 410, 69120 Heidelberg, Deutschland. Michael.Morcos@med.uni-heidelberg.de

Insights

Type 2 diabetes is a growing health burden. Understanding its complex pathophysiology and ancient cellular repair mechanisms is key to developing effective treatments beyond lifestyle changes, which face compliance issues.

Area of Science:

  • Endocrinology
  • Metabolic Disorders
  • Pathophysiology

Background:

  • Type 2 diabetes and impaired glucose tolerance present a significant and increasing global health challenge.
  • The underlying pathophysiology and long-term complications of diabetes are not fully understood, with hyperglycemia being a late indicator of complex metabolic dysfunction.
  • Targeting cellular disorders in diabetes is difficult due to their roots in ancient repair mechanisms, complicating therapeutic development.

Purpose of the Study:

  • To explore the challenges in understanding diabetes pathophysiology.
  • To identify barriers to effective therapeutic targeting.
  • To discuss the difficulties in developing treatment guidelines and the impact of glycaemic memory.

Main Methods:

  • Review of current understanding of diabetes pathophysiology.
  • Analysis of challenges in therapeutic target identification.
  • Discussion of limitations of lifestyle interventions and adherence issues.
  • Examination of the prolonged timelines for clinical studies due to glycaemic memory.

Main Results:

  • Diabetes pathophysiology involves ancient cellular repair mechanisms, making therapeutic targeting complex.
  • Lifestyle interventions are limited by patient compliance.
  • The impact of many diabetes therapies on the whole organism is not well understood.
  • Clinical studies for vascular endpoints require over a decade of data due to glycaemic memory.

Conclusions:

  • Developing effective diabetes treatments requires a deeper understanding of its complex pathophysiology.
  • Overcoming challenges related to cellular mechanisms, patient adherence, and study durations is crucial for advancing diabetes care.
  • Current approaches face limitations, necessitating innovative strategies for therapeutic development and guideline generation.

Related Concept Videos

Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...